Google Alert - "LSD1 inhibitor" OR "sickle cell disease" · Scour

Japan agency grants $32M to advance sickle cell treatment to trials

Agios (AGIO) Files for Accelerated Approval of Mitapivat in Sickle Cell Disease

Affordable Care Act turns 16, but Georgia still hasn't expanded Medicaid

Why Agios Pharmaceuticals (AGIO) Is Up 5.3% After FDA Opens Door To Accelerated Mitapivat Filing

Why Agios Pharmaceuticals Stock Is Up More Than 21% Today

Why Agios Pharmaceuticals Stock Is Up More Than 21% Today

Advancing the Manufacture of Patient Accessible Cell and Gene Therapies at Place-of-Care

Agios eyes accelerated FDA filing for mitapivat | AGIO Stock News

Agios gains on plans to seek FDA accelerated nod for Pyrukynd label expansion

Women's rights are essential for moving global human progress forward

Agios Pharma Rallies On A Surprise FDA Move In Sickle Cell Disease

Low Bone Mineral Density Common in SCD

Finding Courage in a Feathered Friend

Agios Pharmaceuticals Pursues US Accelerated Approval Of Mitapivat For Sickle Cell ...

CRISPR Therapeutics: The Fundamental Standard-Bearer in a Fractured Genomic Sector

Agios Pharmaceuticals Plans Accelerated Approval Filing for Mitapivat in Sickle Cell Disease

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell ...

Agios to pursue accelerated approval for mitapivat in sickle cell

AGIO) announced that, following a successful pre-SNDA meeting with the U.S. Food and ...

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell ...

Log in to enable infinite scrolling